Study of XL820 in Adults With Solid Tumors
NCT00129571
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Cancer
Interventions
DRUG:
XL820
Sponsor
Exelixis